Our data suggest that reducing the expression of Runx1 using dihydrolycorine treatment could rescue the adverse cardiac remodeling that occurs following MI, ultimately preventing the left ventricular dysfunction. The gene discussed is RUNX1; the disease is myocardial infarction.